伊藤 裕幸 | Department of Gastroenterology, Tokai University School of Medicine
スポンサーリンク
概要
Department of Gastroenterology, Tokai University School of Medicine | 論文
- Eight-week oral administration of meloxicam, a non-steroidal anti-inflammatory drug, prevents dose reduction of pegylated interferon α-2a in the treatment of chronic hepatitis C
- An endothelin A receptor antagonist induces dilatation of sinusoidal endothelial fenestrae : implications for endothelin-1 in hepatic microcirculation
- The Serum Soluble HLA-DR Antigens as a Predictive Marker of the Response to Interferon-α Treatment in Patients with Chronic Hepatitis C
- Serum concentrations of soluble HLA-class I and CD8 forms in patients with viral hepatic disorders
- The changes of serum soluble HLA-class I and CD8 concentrations during interferon treatment of chronic hepatitis C patients